Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults

NCT00449436 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

152

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: TRIZIVIR
DRUG: Non-nucleoside reverse transcriptase inhibitor
DRUG: Boosted Protease Inhibitor

Sponsor

GlaxoSmithKline